From: Validation of prognostic scores for survival in cancer patients beyond first-line therapy
Patient Characteristics | Number (Percentage) |
---|---|
Total | 299 (100) |
Age (years) | |
Median [range] | 59 [26-85] |
Gender | |
Male | 79 (26) |
Female | 220 (74) |
ECOG Performance Status | |
0 | 33 (11) |
1 | 134 (45) |
> 1 | 132 (44) |
Weight loss >10% (in the past 6 months) | 63 (22) |
Missing data | 9 |
Primary tumor | |
Breast | 132 (45) |
Lung | 45 (15) |
Ovarian | 34 (11) |
Head and neck | 18 (6) |
Colorectal | 12 (4) |
Soft tissue | 11 (4) |
Other | 47 (16) |
Number of metastatic sites | |
1 | 86 (29) |
2 | 139 (46) |
> 2 | 74 (25) |
Site of metastases | |
Liver | 143 (50) |
Lung | 132 (46) |
Bone | 88 (31) |
Soft tissue | 69 (24) |
Brain | 25 (9) |
Skin | 9 (3) |
Previous treatment | |
Adjuvant chemotherapy | 119 (42) |
Immunotherapy | 29 (10) |
Treatment completed | 131 (49) |
First-line | 70 (26) |
Second-line | 64 (24) |
> Second-line | 34 |
Missing data | |
Treatment after inclusion | |
Chemotherapy | 293 (98) |
Immunotherapy | 5 (2) |
Radiation therapy | 3 (1)† |
Supportive care | 4 (1) |